Controversial AIDS drug for US market.
Barinaga
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004345:Drug Industry / Q000191:economics; D005989:Glycerides / Q000627:therapeutic use*; D006801:Humans; D008389:Marketing of Health Services; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010714:Phosphatidylethanolamines / Q000627:therapeutic use*; D014481:United States
D004338:Drug Combinations; D005989:Glycerides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination